|
시장보고서
상품코드
2058365
메타돈 염산염 시장 : 제형별, 용도별, 투여 경로별, 유통 채널별, 지역별Methadone Hydrochloride Market, By Formulation, By Application, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
메타돈 염산염 시장은 2026년에 1억 3,680만 달러로 추정되며, 2033년까지 1억 8,630만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 4.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 1억 3,680만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 4.50% | 2033년 시장 규모 예측: | 1억 8,630만 달러 |
합성 아편성 진통제인 메타돈은 오피오이드라고 불리는 범주에 속합니다. 이 오피오이드는 모르핀과 질적으로 유사한 약리 작용을 나타냅니다. 메타돈은 일반적으로 진통제로, 또한 약물 의존증의 해독 요법이나 유지 요법의 일환으로 사용됩니다. 통증에는 수술로 인한 것, 근육 긴장으로 인한 것 등 다양한 종류가 있습니다. 심한 만성 통증을 겪는 환자에게는 소량의 메타돈이 투여됩니다. 메타돈은 뇌와 신경계가 통증에 반응하는 방식을 변화시켜 통증을 완화합니다. 오피오이드 의존증은 심각한 공중보건 문제로 대두되고 있습니다.
시장 역학
주요 기업들은 세계 메타돈 염산염 시장에서의 입지를 강화하기 위해 합병 및 인수에 주력하고 있습니다. 예를 들어, 2016년 5월, 히크마 파마슈티컬스(Hikma Pharmaceuticals PLC)는 제약 회사인 록산 래버러토리스(Roxane Laboratories, Inc.)를 인수했습니다. 이번 인수를 통해 해당 기업은 록산 래버러토리즈(Roxan Laboratories)로부터 메타돈 염산염을 확보함으로써 오피오이드 작용제 제품 포트폴리오를 확대했습니다.
본 조사의 주요 특징
- 본 보고서는 전 세계 메타돈 염산염 시장의 현황 및 향후 시장 잠재력을 조사하고 있습니다. 메타돈 염산염 시장은 제형, 용도, 투여 경로, 유통 채널 및 지역별로 세분화되어 있습니다.
- 본 보고서는 전 세계 메타돈 염산염 시장에 대한 상세한 분석을 바탕으로, 예측 기간(2026-2033년) 동안의 시장 규모 및 연평균 성장률(CAGR, %)을 제시하고 있습니다.
- 본 보고서는 각 부문별 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다. 또한 시장 촉진요인, 제약요인, 기회, 지역별 전망 및 주요 기업들이 채택하고 있는 경쟁 전략에 관한 귀중한 인사이트를 제공합니다.
- 본 보고서에서는 다음의 매개변수를 바탕으로 전 세계 메타돈 염산염 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업 개요, 재무 실적, 제품 포트폴리오, 사업 지역, 주요 발전 사항 및 향후 계획입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 시장 확대와 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 시장 보고서는 투자자, 제품 개발자 및 제조업체, 유통업체, 의료 기관, 연구 기관, 신규 진입 기업, 금융 애널리스트 등 해당 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 메타돈 염산염 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정에 큰 도움을 받으실 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 메타돈 염산염 시장 : 제제별, 2021-2033년
제5장 세계의 메타돈 염산염 시장 : 용도별, 2021-2033년
제6장 세계의 메타돈 염산염 시장 : 투여 경로별, 2021-2033년
제7장 세계의 메타돈 염산염 시장 : 유통 채널별, 2021-2033년
제8장 세계의 메타돈 염산염 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.06.19Methadone Hydrochloride Market is estimated to be valued at USD 136.8 Mn in 2026 and is expected to reach USD 186.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 136.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.50% | 2033 Value Projection: | USD 186.3 Mn |
Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.
Market Dynamics
Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc
Key features of the study
- This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
- This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
- It profiles leading players in the global methadone hydrochloride market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
- Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
- The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
- Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market
Market Segmentation
- By Formulation Insights (Revenue, USD Mn, 2021 - 2033)
- Tablet
- Solution
- Others
- By Application Insights (Revenue, USD Mn, 2021 - 2033)
- Opiate Withdrawal
- Chronic Pain
- Others
- By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Oral
- Intravenous
- By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Eli Lilly and Company
- Sanofi S.A
- Hikma Pharmaceuticals PLC
- Mallinckrodt Pharmaceuticals
- Siegfried Holding AG
- Johnson Matthey
- Tianjin Central Pharmaceutical Co., Ltd
- Temad Co
- Embio LTD
- Harman Finochem Ltd
- Rusan Pharma Ltd
Table of Content
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Formulation
- Market Snapshot, By Application
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Drivers and Restraints
- Opportunities
- Impact Analysis
- Recent Product launches and Approvals
- Pipeline Analysis
- Brand Analysis
- Regulatory Scenario
- PEST Analysis
- Epidemiology
- Reimbursement Scenario
- Acquisition
- Market Trend
4. Global Methadone Hydrochloride Market, By Formulation, 2021-2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Methadone Hydrochloride Market, By Application, 2021-2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Opiate Withdrawal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chronic Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Methadone Hydrochloride Market, By Route of Administration, 2021-2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Methadone Hydrochloride Market, By Distribution Channel, 2021-2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Methadone Hydrochloride Market, By Region, 2021-2033 (USD Mn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Countries, 2022-2033
- North America
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country, 2021-2033 (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Formulation, 2021-2033 (USD Mn)
- Market Size and Forecast, By Application 2021-2033 (USD Mn)
- Market Size and Forecast, By Route of Administration, 2021-2033 (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021-2033 (USD Mn)
- Market Size and Forecast, By Country/Region, 2021-2033 (USD Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Company Profiles
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi S.A
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Hikma Pharmaceuticals PLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mallinckrodt Pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siegfried Holding AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson Matthey
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Tianjin Central Pharmaceutical Co., Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Temad Co
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Embio LTD
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Harman Finochem Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rusan Pharma Ltd
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst View
- Eli Lilly and Company
10. Section
- References
- Research Methodology
- About Us
